510(k) Report

PMA · Approved

Recalled · Class II · 2023

Zephyr Endobronchial Valve System

P180002PMAApproved Jun 29, 2018178-day reviewClass IIIRecalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pulmonx Corporation · NJK Valve, Pulmonary

Approved on Jun 29, 2018 through premarket approval, which rests on the device’s own clinical evidence after a 178-day review. It has been recalled once.

Decided
Jun 29, 2018
Review
178 days
Class
Class III
Product code
NJK
Recalls
1

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P180002 has 29 supplements since 2018: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2018: 22019: 122020: 32021: 12022: 12023: 22024: 52026: 3
2018high 12 (2019) · low 0 (2025)2026
View FIG. 1 as a table
YearSupplements approved
20182
201912
20203
20211
20221
20232
20245
20263
FIG. 1 — Supplements to P180002, 2018–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NJK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 31, 2023Class IIZ-0235-2024Error in labelingEndobronchial implant devices may have been labeled with a shortened expiration date but they can be used until the correct expiration date: 08 December 2024.

No ancestor or descendant has a Class I recall.

How does its category compare?

All NJK devices

NJK Valve, Pulmonary: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · NJK

7in 2024

2018: 42019: 142020: 52021: 22022: 22023: 32024: 72026 (partial year): 5
2007high 14 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NJK

Too few NJK 510(k)s in any year since 2007 to give a median.

Recalls per year · NJK

1in 2023

2021: 12023: 1
2007high 1 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NJK

145in 2025

2018: 142019: 2152020: 3442021: 4052022: 3422023: 2662024: 1762025: 145
2007high 405 (2021) · low 0 (2007)2025

MAUDE reports naming product code NJK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20184—014
201914—0215
20205—0344
20212—1405
20222—0342
20233—1266
20247—0176
20250—0145
20265—0—
Cite this page

510(k) Report. “P180002: Zephyr Endobronchial Valve System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P180002

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026